Below are current clinical trials.2 studies in Gastrointestinal Barrier Function: Madhusudan (Madhu) Grover
(all studies, either open or closed).
Filter this list of studies by location, status and more.
This study is to evaluate the effectiveness of the investigational drug motilitone at 90 mg in patients with functional dyspepsia as measured by change in maximum tolerated volume and the aggregate symptom score on the nutrient drink test.
The investigators' overall objective with this study is to determine performance characteristics of small intestine permeability measurement using 13C mannitol and 12C (regular) mannitol.